Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 1
2011 1
2013 1
2014 2
2015 3
2016 1
2017 3
2018 7
2019 9
2020 6
2021 12
2022 10
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2.
Reiss KA, Mick R, O'Hara MH, Teitelbaum U, Karasic TB, Schneider C, Cowden S, Southwell T, Romeo J, Izgur N, Hannan ZM, Tondon R, Nathanson K, Vonderheide RH, Wattenberg MM, Beatty G, Domchek SM. Reiss KA, et al. J Clin Oncol. 2021 Aug 1;39(22):2497-2505. doi: 10.1200/JCO.21.00003. Epub 2021 May 10. J Clin Oncol. 2021. PMID: 33970687 Clinical Trial.
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
Reiss KA, Mick R, Teitelbaum U, O'Hara M, Schneider C, Massa R, Karasic T, Tondon R, Onyiah C, Gosselin MK, Donze A, Domchek SM, Vonderheide RH. Reiss KA, et al. Lancet Oncol. 2022 Aug;23(8):1009-1020. doi: 10.1016/S1470-2045(22)00369-2. Epub 2022 Jul 7. Lancet Oncol. 2022. PMID: 35810751 Free PMC article. Clinical Trial.
PARP Inhibitors in Pancreatic Cancer.
Brown TJ, Reiss KA. Brown TJ, et al. Among authors: reiss ka. Cancer J. 2021 Nov-Dec 01;27(6):465-475. doi: 10.1097/PPO.0000000000000554. Cancer J. 2021. PMID: 34904809 Free PMC article. Review.
Targeting BRCA and PALB2 in Pancreatic Cancer.
Anbil S, Reiss KA. Anbil S, et al. Among authors: reiss ka. Curr Treat Options Oncol. 2024 Mar;25(3):346-363. doi: 10.1007/s11864-023-01174-0. Epub 2024 Jan 4. Curr Treat Options Oncol. 2024. PMID: 38311708 Review.
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival.
Boursi B, Wileyto EP, Mamtani R, Domchek SM, Golan T, Hood R, Reiss KA. Boursi B, et al. Among authors: reiss ka. JAMA Netw Open. 2023 Nov 1;6(11):e2345013. doi: 10.1001/jamanetworkopen.2023.45013. JAMA Netw Open. 2023. PMID: 38010655 Free PMC article.
Healthy, but comatose.
Houston B, Reiss KA, Merlo C. Houston B, et al. Among authors: reiss ka. Am J Med. 2011 Apr;124(4):303-5. doi: 10.1016/j.amjmed.2010.12.002. Am J Med. 2011. PMID: 21435419 No abstract available.
Immune Therapy in GI Malignancies: A Review.
Wang J, Reiss KA, Khatri R, Jaffee E, Laheru D. Wang J, et al. Among authors: reiss ka. J Clin Oncol. 2015 Jun 1;33(16):1745-53. doi: 10.1200/JCO.2015.60.7879. Epub 2015 Apr 27. J Clin Oncol. 2015. PMID: 25918295 Free PMC article. Review.
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers.
Wineland D, Le AN, Hausler R, Kelly G, Barrett E, Desai H, Wubbenhorst B, Pluta J, Bastian P, Symecko H, D'Andrea K, Doucette A, Gabriel P, Reiss KA, Nayak A, Feldman M, Domchek SM, Nathanson KL, Maxwell KN; Regeneron Genetics Center; Penn Medicine Biobank. Wineland D, et al. Among authors: reiss ka. JCO Precis Oncol. 2023 Aug;7:e2300036. doi: 10.1200/PO.23.00036. JCO Precis Oncol. 2023. PMID: 37535879 Free PMC article.
58 results